Menu
A stealthy Longwood-based startup with a prolific top executive raised nearly $5 million in investment capital.
Health tech firm NeuTrace Inc. raised $4.8 million, according to a June 15 U.S. Securities and Exchange Commission filing. The company does not boast a prolific public profile, lacking even a website. However, it has attracted more than $7 million in investment since Sept. 15 to find new diagnosis methods and treatments for heart disorders with the aid of artificial intelligence and machine learning.
NeuTrace was founded in 2020, and business analytics firm CB Insights classifies the company as being in “stealth mode,” a term for startups in a state of secretiveness to avoid alerting competitors to what they are working on.
What is not a secret is NeuTrace is led by an accomplished physician in President and Chief Operating Officer Dr. Srijoy Mahapatra. Mahapatra serves as chief strategy officer of Fairview Ventures, an innovation lab operated by Minneapolis-based nonprofit health care system Fairview Health Services.
